Header Logo

Connection

Yuki Kageyama to Urinary Bladder Neoplasms

Back to Details
This is a "connection" page, showing publications Yuki Kageyama has written about Urinary Bladder Neoplasms.
Yuki Kageyama
Connection Strength
2.820
Urinary Bladder Neoplasms
  1. Platelet-to-Lymphocyte Ratio Predicts the Efficacy of Pembrolizumab in Patients With Urothelial Carcinoma. Anticancer Res. 2022 Feb; 42(2):1131-1136.
    View in: PubMed
    Score: 0.553
  2. STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-?-induced Apoptosis in Urothelial Cancer. Anticancer Res. 2024 May; 44(5):1925-1930.
    View in: PubMed
    Score: 0.162
  3. Favorable outcome of preoperative low dose chemoradiotherapy against muscle-invasive bladder cancer. Am J Clin Oncol. 2003 Oct; 26(5):504-7.
    View in: PubMed
    Score: 0.155
  4. A Case of Immune Thrombocytopenia Occurring after Radiotherapy plus Atezolizumab Treatment for Bladder Cancer. Gan To Kagaku Ryoho. 2023 Sep; 50(9):985-992.
    View in: PubMed
    Score: 0.154
  5. Efficacy and Safety of Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Interim Analysis from a Multicenter, Open-label, Prospective Phase 2 Trial. Int J Radiat Oncol Biol Phys. 2023 11 01; 117(3):644-651.
    View in: PubMed
    Score: 0.151
  6. [Neoadjuvant chemotherapy for invasive bladder cancer]. Gan To Kagaku Ryoho. 2001 Nov; 28(12):1838-44.
    View in: PubMed
    Score: 0.136
  7. Preoperative concurrent chemoradiotherapy against muscle-invasive bladder cancer: results of partial cystectomy in elderly or high-risk patients. Jpn J Clin Oncol. 2000 Dec; 30(12):553-6.
    View in: PubMed
    Score: 0.128
  8. Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: A preliminary study. Cancer Med. 2020 11; 9(22):8355-8363.
    View in: PubMed
    Score: 0.125
  9. Randomized Study of Postoperative Single Intravesical Instillation With Pirarubicin and Mitomycin C for Low-risk Bladder Cancer. Anticancer Res. 2020 Sep; 40(9):5295-5299.
    View in: PubMed
    Score: 0.125
  10. [Three Successful TUR Treatments of Urinary Bladder Recurrence of Colorectal Carcinoma]. Gan To Kagaku Ryoho. 2016 Nov; 43(12):1638-1640.
    View in: PubMed
    Score: 0.096
  11. Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study. BJU Int. 2009 Jul; 104(2):189-94.
    View in: PubMed
    Score: 0.056
  12. Clinical outcome of chemoradiotherapy for T1G3 bladder cancer. Int J Urol. 2008 Aug; 15(8):747-50.
    View in: PubMed
    Score: 0.054
  13. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis. Urology. 2008 Aug; 72(2):384-8.
    View in: PubMed
    Score: 0.053
  14. [Effect of a calcium influx blocker, verapamil, on the sensitivity of human bladder cancer cells to adriamycin and mitomycin C]. Gan To Kagaku Ryoho. 1988 May; 15(5):1727-31.
    View in: PubMed
    Score: 0.053
  15. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy. BJU Int. 2008 Apr; 101(8):978-81.
    View in: PubMed
    Score: 0.052
  16. [Bladder preservation by chemoradiotherapy in combination with radical TUR-Bt in muscle invasive bladder cancer]. Nihon Hinyokika Gakkai Zasshi. 2007 Sep; 98(6):752-6.
    View in: PubMed
    Score: 0.051
  17. HSP60 may predict good pathological response to neoadjuvant chemoradiotherapy in bladder cancer. Jpn J Clin Oncol. 2007 Jan; 37(1):56-61.
    View in: PubMed
    Score: 0.048
  18. [A case of secondary malignant lymphoma of the urinary bladder]. Hinyokika Kiyo. 2006 Apr; 52(4):285-7.
    View in: PubMed
    Score: 0.046
  19. [A large amount of distilled water ineffective for prevention of bladder cancer cell implantation at the time of transurethral resection]. Hinyokika Kiyo. 2006 Mar; 52(3):173-5.
    View in: PubMed
    Score: 0.046
  20. Prognostic significance of endothelial Per-Arnt-sim domain protein 1/hypoxia-inducible factor-2alpha expression in a subset of tumor associated macrophages in invasive bladder cancer. J Urol. 2004 Mar; 171(3):1080-4.
    View in: PubMed
    Score: 0.040
  21. Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin Cancer Res. 2003 Nov 15; 9(15):5501-7.
    View in: PubMed
    Score: 0.039
  22. Adenocarcinoma arising at the ileoileal anastomotic site of Scheele's ring. Int J Urol. 2003 Sep; 10(9):495-7.
    View in: PubMed
    Score: 0.039
  23. Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypes of urothelial neoplasms. Br J Cancer. 2003 Mar 10; 88(5):740-7.
    View in: PubMed
    Score: 0.037
  24. IFN gamma-induced up-regulation of PD-ECGF/TP enhances the cytotoxicity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in bladder cancer cells. Anticancer Res. 2002 Sep-Oct; 22(5):2607-12.
    View in: PubMed
    Score: 0.036
  25. Positive expression of HIF-2alpha/EPAS1 in invasive bladder cancer. Urology. 2002 May; 59(5):774-8.
    View in: PubMed
    Score: 0.035
  26. Inhibitory effect of N-acetylcysteine on invasion and MMP-9 production of T24 human bladder cancer cells. Anticancer Res. 2001 Jan-Feb; 21(1A):213-9.
    View in: PubMed
    Score: 0.032
  27. Significance of carbohydrate antigen sialyl-Lewis X, sialyl-Lewis A, and possible unknown ligands to adhesion of human urothelial cancer cells to activated endothelium. Urol Int. 2000; 64(3):129-33.
    View in: PubMed
    Score: 0.030
  28. Late recurrence and progression after a long tumor-free period in primary Ta and T1 bladder cancer. Eur Urol. 1999 Oct; 36(4):309-13.
    View in: PubMed
    Score: 0.029
  29. Detection of disseminated urothelial cancer cells in peripheral venous blood by a cytokeratin 20-specific nested reverse transcriptase-polymerase chain reaction. Jpn J Cancer Res. 1999 Jul; 90(7):753-7.
    View in: PubMed
    Score: 0.029
  30. Significance of bladder neck involvement on progression in superficial bladder cancer. Eur Urol. 1998; 33(5):464-8.
    View in: PubMed
    Score: 0.026
  31. Telomere length and telomerase activity in bladder and prostate cancer cell lines. Int J Urol. 1997 Jul; 4(4):407-10.
    View in: PubMed
    Score: 0.025
  32. Bacillus Calmette-Gu?rin enhances production and secretion of type IV collagenases in peripheral blood mononuclear cells. Jpn J Cancer Res. 1997 Mar; 88(3):281-8.
    View in: PubMed
    Score: 0.025
  33. Significant telomere reduction in human superficial transitional cell carcinoma. Br J Urol. 1996 Nov; 78(5):704-8.
    View in: PubMed
    Score: 0.024
  34. [En bloc cystourethrectomy with preservation of potency]. Nihon Hinyokika Gakkai Zasshi. 1996 Mar; 87(3):676-81.
    View in: PubMed
    Score: 0.023
  35. Infrequent mutations of the WT1 gene in primary cancers of the adult urinary tract. Jpn J Clin Oncol. 1995 Oct; 25(5):173-8.
    View in: PubMed
    Score: 0.022
  36. Detection of P-glycoprotein in human urogenital carcinomas and its relationship to epidermal growth factor receptor expression. Eur Urol. 1991; 20(1):58-61.
    View in: PubMed
    Score: 0.016
  37. [A study of cytokeratin in human normal bladder epithelium and bladder carcinoma cell lines]. Hinyokika Kiyo. 1990 Aug; 36(8):903-6; Discussion 906-7.
    View in: PubMed
    Score: 0.016
  38. [A study of intercellular communication of human transitional cell carcinoma cell lines]. Nihon Hinyokika Gakkai Zasshi. 1989 Jul; 80(7):988-94.
    View in: PubMed
    Score: 0.014
  39. [The clinical study of 23 cases in patients with bladder cancer over 85 years old]. Hinyokika Kiyo. 1989 Jul; 35(7):1141-4.
    View in: PubMed
    Score: 0.014
  40. [Urinary bladder tumor manifesting multiple bone metastases similar to prostatic carcinoma--a case report]. Gan No Rinsho. 1988 Jan; 34(1):111-4.
    View in: PubMed
    Score: 0.013
  41. Successful treatment of metastatic adenocarcinoma of the urachus: report of 2 cases with more than 10-year survival. Urology. 2001 Sep; 58(3):462.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.